Stay updated on Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.

Latest updates to the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedAdded a new MedlinePlus Genetics topic: Ovarian cancer, expanding the page's coverage to include genetic information about ovarian cancer.SummaryDifference0.2%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdd: new government funding/status notice and v3.2.0; Remove: old ovarian cancer topic listing and v3.1.0.SummaryDifference3%
- Check24 days agoChange Detected- Added: Revision: v3.1.0. - Removed: a specific resource (Ovarian cancer) under Genetic and Rare Diseases Information Center resources and the older Revision: v3.0.2.SummaryDifference0.4%
- Check38 days agoChange DetectedAdded a new MedlinePlus Genetics topic on Ovarian cancer and updated to v3.0.2; removed the 'Back to Top' link.SummaryDifference0.4%
- Check46 days agoChange DetectedThe page has been updated to version 3.0.1, and the section on ovarian cancer related to MedlinePlus Genetics has been removed.SummaryDifference0.4%
- Check53 days agoChange DetectedThe web page has updated its facility name and location details, specifically changing the reference to Washington D.C. and adding new scientific terms related to proteins and cancer treatment.SummaryDifference3%
Stay in the know with updates to Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fostamatinib Comb-Paclitaxel in Ovarian Cancer Clinical Trial page.